Home › Galena Biopharma to Present GALE-302 Preliminary Immunological Data...
 

Keywords :   


Galena Biopharma to Present GALE-302 Preliminary Immunological Data...

2015-10-22 21:17:07| Biotech - Topix.net

Galena Biopharma to Present GALE-302 Preliminary Immunological Data Optimizing GALE-301, and the Phase 2 NeuVax Data Impact on Cancer Survivorship at Two Upcoming Medical Conferences SAN RAMON, Calif., Oct. 22, 2015 -- Galena Biopharma, Inc. , a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced that data from the Company's NeuVax and GALE-301 and GALE-302 clinical programs will be presented at two upcoming medical conferences.

Tags: data present preliminary immunological

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.07Millicom believes takeover offer by Atlas undervalues the company
04.07Passes selects Bitmovin Player and Analytics to empower creators
04.07German study shows high consumer interest in 5G broadcast
04.07Tropical Depression One-E Graphics
04.07Tropical Depression One-E Forecast Discussion Number 1
04.07Tropical Depression One-E Wind Speed Probabilities Number 1
04.07Tropical Depression One-E Public Advisory Number 1
04.07Summary for Tropical Depression One-E (EP1/EP012024)
More »